MegestrolAcetateTripleNegativeBreastCancerChemopreventionMultifocalTumorsMorpheaTumorGradeOligometastasesBrachytherapyAdjuvantTherapyLumpStagingCAMBilateralProphylacticMastectomy5-FluorouracilPrecisionMedicineHormoneReplacementTherapyMethotrexateRelapseWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.FlowCytometryFamilyHistoryCDK4/6InhibitorsPaclitaxelDoseDenseTherapyCytostaticDown-StagingBevacizumabTriplePositiveBreastCancerDocetaxelBOCAPalbociclibRadiotherapyPagetDiseaseCheckpointInhibitorECOGScoreCystPI3KinaseInhibitorsKi-67RateCapecitabineAdenocarcinomaAbsoluteRiskTyrosine-KinaseInhibitorBreastTomosynthesisHER-2Estimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearSERMACChemotherapyGailModelAngiogenesisGermlineMutationBiopsyMastectomyRaloxifeneImmunotherapyFISHFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ExcisionalBiopsyLapatinibCachexiaAromataseInhibitorsMastodyniaCytotoxicAnastrozoleAyurveda1 in 8womenCo-survivorMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltER+MetastasisIntraductalPapillomaLumpectomyFibroadenomaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTamoxifenHerceptinPARPInhibitorsProgestinBRCAGenePhysicalactivity mayreduce therisk of breastcancersBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55ApoptosisNeoadjuvantTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancermTORInhibitorsNodePositivePathologicResponseEstrogenGeneMutationIn-situCarcinomaAntibodyTherapyEstradiolLymphNodeStatusHormoneReceptorStatusEGFR(epidermalgrowth factorreceptor)ChemotherapyNeoplasmWomen ages40+ shouldhave a clinicalbreast examat least yearlyER-Self-examinationAlopeciaGuaranteedRenewableInsuranceDoxorubicinAdvocacyDimplingGeneticCounselingBI-RADSOvarianSuppressionMRIPhyllodesTumorAntiemeticRADCMFChemotherapyPalpationKappaEpsilonBreastCancerMultimodalityTherapyCyclophosphamideGenomicTestingLymphoscintigraphyNodeNegativeInvasiveBreastCancerCalcificationsDefinitiveSurgeryLCISAxillarySamplingGeneticPredispositionMegestrolAcetateTripleNegativeBreastCancerChemopreventionMultifocalTumorsMorpheaTumorGradeOligometastasesBrachytherapyAdjuvantTherapyLumpStagingCAMBilateralProphylacticMastectomy5-FluorouracilPrecisionMedicineHormoneReplacementTherapyMethotrexateRelapseWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.FlowCytometryFamilyHistoryCDK4/6InhibitorsPaclitaxelDoseDenseTherapyCytostaticDown-StagingBevacizumabTriplePositiveBreastCancerDocetaxelBOCAPalbociclibRadiotherapyPagetDiseaseCheckpointInhibitorECOGScoreCystPI3KinaseInhibitorsKi-67RateCapecitabineAdenocarcinomaAbsoluteRiskTyrosine-KinaseInhibitorBreastTomosynthesisHER-2Estimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearSERMACChemotherapyGailModelAngiogenesisGermlineMutationBiopsyMastectomyRaloxifeneImmunotherapyFISHFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.ExcisionalBiopsyLapatinibCachexiaAromataseInhibitorsMastodyniaCytotoxicAnastrozoleAyurveda1 in 8womenCo-survivorMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltER+MetastasisIntraductalPapillomaLumpectomyFibroadenomaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTamoxifenHerceptinPARPInhibitorsProgestinBRCAGenePhysicalactivity mayreduce therisk of breastcancersBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55ApoptosisNeoadjuvantTherapyAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancermTORInhibitorsNodePositivePathologicResponseEstrogenGeneMutationIn-situCarcinomaAntibodyTherapyEstradiolLymphNodeStatusHormoneReceptorStatusEGFR(epidermalgrowth factorreceptor)ChemotherapyNeoplasmWomen ages40+ shouldhave a clinicalbreast examat least yearlyER-Self-examinationAlopeciaGuaranteedRenewableInsuranceDoxorubicinAdvocacyDimplingGeneticCounselingBI-RADSOvarianSuppressionMRIPhyllodesTumorAntiemeticRADCMFChemotherapyPalpationKappaEpsilonBreastCancerMultimodalityTherapyCyclophosphamideGenomicTestingLymphoscintigraphyNodeNegativeInvasiveBreastCancerCalcificationsDefinitiveSurgeryLCISAxillarySamplingGeneticPredisposition

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Megestrol Acetate
  2. Triple Negative Breast Cancer
  3. Chemoprevention
  4. Multifocal Tumors
  5. Morphea
  6. Tumor Grade
  7. Oligometastases
  8. Brachytherapy
  9. Adjuvant Therapy
  10. Lump
  11. Staging
  12. CAM
  13. Bilateral Prophylactic Mastectomy
  14. 5-Fluorouracil
  15. Precision Medicine
  16. Hormone Replacement Therapy
  17. Methotrexate
  18. Relapse
  19. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  20. Flow Cytometry
  21. Family History
  22. CDK4/6 Inhibitors
  23. Paclitaxel
  24. Dose Dense Therapy
  25. Cytostatic
  26. Down-Staging
  27. Bevacizumab
  28. Triple Positive Breast Cancer
  29. Docetaxel
  30. BOCA
  31. Palbociclib
  32. Radiotherapy
  33. Paget Disease
  34. Checkpoint Inhibitor
  35. ECOG Score
  36. Cyst
  37. PI3 Kinase Inhibitors
  38. Ki-67 Rate
  39. Capecitabine
  40. Adenocarcinoma
  41. Absolute Risk
  42. Tyrosine-Kinase Inhibitor
  43. Breast Tomosynthesis
  44. HER-2
  45. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  46. SERM
  47. AC Chemotherapy
  48. Gail Model
  49. Angiogenesis
  50. Germline Mutation
  51. Biopsy
  52. Mastectomy
  53. Raloxifene
  54. Immunotherapy
  55. FISH
  56. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  57. Excisional Biopsy
  58. Lapatinib
  59. Cachexia
  60. Aromatase Inhibitors
  61. Mastodynia
  62. Cytotoxic
  63. Anastrozole
  64. Ayurveda
  65. 1 in 8 women
  66. Co-survivor
  67. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  68. ER+
  69. Metastasis
  70. Intraductal Papilloma
  71. Lumpectomy
  72. Fibroadenoma
  73. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  74. Tamoxifen
  75. Herceptin
  76. PARP Inhibitors
  77. Progestin
  78. BRCA Gene
  79. Physical activity may reduce the risk of breast cancers
  80. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  81. Apoptosis
  82. Neoadjuvant Therapy
  83. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  84. mTOR Inhibitors
  85. Node Positive
  86. Pathologic Response
  87. Estrogen
  88. Gene Mutation
  89. In-situ Carcinoma
  90. Antibody Therapy
  91. Estradiol
  92. Lymph Node Status
  93. Hormone Receptor Status
  94. EGFR (epidermal growth factor receptor)
  95. Chemotherapy
  96. Neoplasm
  97. Women ages 40+ should have a clinical breast exam at least yearly
  98. ER-
  99. Self-examination
  100. Alopecia
  101. Guaranteed Renewable Insurance
  102. Doxorubicin
  103. Advocacy
  104. Dimpling
  105. Genetic Counseling
  106. BI-RADS
  107. Ovarian Suppression
  108. MRI
  109. Phyllodes Tumor
  110. Antiemetic
  111. RAD
  112. CMF Chemotherapy
  113. Palpation
  114. Kappa Epsilon
  115. Breast Cancer
  116. Multimodality Therapy
  117. Cyclophosphamide
  118. Genomic Testing
  119. Lymphoscintigraphy
  120. Node Negative
  121. Invasive Breast Cancer
  122. Calcifications
  123. Definitive Surgery
  124. LCIS
  125. Axillary Sampling
  126. Genetic Predisposition